Prevention of percutaneous driveline infection after left ventricular assist device implantation: Prophylactic antibiotics are not necessary

ASAIO Journal

Volumn 59, Issue 6, 2013, Pages 570-574

  Stulak, John M ^a   Maltais, Simon ^b   Cowger, Jennifer ^c   Joyce, Lyle D ^a   Daly, Richard C ^a   Park, Soon J ^a   Aaronson, Keith D ^c   Pagani, Francis D ^c  

^a Mayo Clinic   (United States)

^b VANDERBILT UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

driveline; infection; mechanical circulatory support

Indexed keywords

DESTINATION THERAPY; DRIVELINES; INFECTION; MAINTENANCE STRATEGIES; MECHANICAL CIRCULATORY SUPPORT; PREVENTION STRATEGIES; UNIVERSITY OF MICHIGAN; VENTRICULAR ASSIST DEVICE;

LEFT VENTRICULAR ASSIST DEVICES;

ANTIBIOTICS;

CHLORHEXIDINE GLUCONATE; DOXYCYCLINE; LEVOFLOXACIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DEVICE INFECTION; DRIVELINE INFECTION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; METAL IMPLANTATION; PERCUTANEOUS DRAINAGE; PRIORITY JOURNAL; SURVIVOR; VENTRICULAR ASSIST DEVICE;

ANTI-BACTERIAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS;

EID: 84887221399     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3182a9e2a5     Document Type: Article

References (22)

1. Rose EA, Gelijns AC, Moskowitz AJ, et al; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group: Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345: 1435-1443, 2001.
2. Kirklin JK, Naftel DC, Kormos RL, et al: The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant 31: 117-126, 2012.
3. Sun BC, Catanese KA, Spanier TB, et al: 100 long-term implantable left ventricular assist devices: The Columbia Presbyterian interim experience. Ann Thorac Surg 68: 688-694, 1999. (Pubitemid 29521153)
4. Gordon RJ, Quagliarello B, Lowy FD: Ventricular assist devicerelated infections. Lancet Infect Dis 6: 426-437, 2006.
5. Goldstein DJ, Naftel D, Holman W, et al: Continuous-flow devices and percutaneous site infections: Clinical outcomes. J Heart Lung Transplant 31: 1151-1157, 2012.
6. Raymond AL, Kfoury AG, Bishop CJ, et al: Obesity and left ventricular assist device driveline exit site infection. ASAIO J 56: 57-60, 2010.
7. Simon D, Fischer S, Grossman A, et al: Left ventricular assist device-related infection: Treatment and outcome. Clin Infect Dis 40: 1108-1115, 2005. (Pubitemid 40490234)
8. Pereda D, Conte JV: Left ventricular assist device driveline infections. Cardiol Clin 29: 515-527, 2011.
9. Schaffer JM, Allen JG, Weiss ES, et al: Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation. J Heart Lung Transplant 30: 164-174, 2011.
10. Topkara VK, Kondareddy S, Malik F, et al: Infectious complications in patients with left ventricular assist device: Etiology and outcomes in the continuous-flow era. Ann Thorac Surg 90: 1270-1277, 2010.
11. Sharma V, Deo SV, Stulak JM, et al: Driveline infections in left ventricular assist devices: Implications for destination therapy. Ann Thorac Surg 94: 1381-1386, 2012.
12. Zierer A, Melby SJ, Voeller RK, et al: Late-onset driveline infections: The Achilles' heel of prolonged left ventricle assist device support. Ann Thorac Surg 90: 1270-1277, 2007.
13. Jarvik R, Westaby S, Katsumata T, Pigott D, Evans RD: LVAD power delivery: A percutaneous approach to avoid infection. Ann Thorac Surg 65: 470-473, 1998. (Pubitemid 28083347)
14. Sivaratnam K, Duggan JM: Left ventricular assist device infections: Three case reports and a review of the literature. ASAIO J 48: 2-7, 2002. (Pubitemid 34575760)
15. Vilchez RA, McEllistrem MC, Harrison LH, McCurry KR, Kormos RL, Kusne S: Relapsing bacteremia in patients with ventricular assist device: An emergent complication of extended circulatory support. Ann Thorac Surg 72: 96-101, 2001. (Pubitemid 32643016)
16. Herrmann M, Weyand M, Greshake B, et al: Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation 95: 814-817, 1997. (Pubitemid 27091519)
17. Argenziano M, Catanese KA, Moazami N, et al: The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant 16: 822-831, 1997. (Pubitemid 27362682)
18. Prendergast TW, Todd BA, Beyer AJ 3rd, et al: Management of left ventricular assist device infection with heart transplantation. Ann Thorac Surg 64: 142-147, 1997. (Pubitemid 27313895)
19. Stulak JM, Cowger J, Haft JW, Romano MA, Aaronson KD, Pagani FD: Device exchange after primary left ventricular assist device implantation: Indications and outcomes. Ann Thorac Surg 95: 1262-1267; discussion 1267, 2013.
20. Baradarian S, Stahovich M, Krause S, Adamson R, Dembitsky W: Case series: Clinical management of persistent mechanical assist device driveline drainage using vacuum-assisted closure therapy. ASAIO J 52: 354-356, 2006. (Pubitemid 44314888)
21. Yuh DD, Albaugh M, Ullrich S, Conte JV: Treatment of ventricular assist device driveline infection with vacuum-assisted closure system. Ann Thorac Surg 80: 1493-1495, 2005. (Pubitemid 41354148)
22. Argenta LC, Morykwas MJ: Vacuum-assisted closure: A new method for wound control and treatment: Clinical experience. Ann Plast Surg 38: 563-576; discussion 577, 1997.